Atlas Trials

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Clinical trial NCT03693326 · UNKNOWN

Trial details

NCT number
NCT03693326
Sponsor
Asan Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
CancerLung Cancer MetastaticImmunotherapy
Start date
2018-11-01
Primary completion
2020-06-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.